Medication Management and ICU Plan for Acute Heart Failure
For patients with acute heart failure, intravenous furosemide should be administered immediately, with dosing based on prior diuretic exposure: 40mg IV for new-onset heart failure or a bolus at least equivalent to the oral dose for established heart failure patients. 1, 2
Initial Assessment and Monitoring
Implement continuous cardiac monitoring with:
- Pulse oximetry
- Blood pressure monitoring (every 15-30 minutes initially)
- Continuous ECG telemetry
- Frequent respiratory rate assessment
- Strict input/output monitoring
Obtain baseline laboratory studies:
- Complete blood count
- Comprehensive metabolic panel
- Cardiac biomarkers
- Arterial or venous blood gas
- Natriuretic peptide levels
Perform chest X-ray and consider echocardiography if hemodynamically unstable
Respiratory Management
For SpO₂ <90% or PaO₂ <60 mmHg:
- Start supplemental oxygen, targeting SpO₂ 88-92%
- Avoid hyperoxia which can cause vasoconstriction and reduced cardiac output
For respiratory distress:
- Initiate non-invasive ventilation (NIV) promptly
- Use continuous positive airway pressure (CPAP) if available in pre-hospital setting
- Consider pressure-support positive end-expiratory pressure (PS-PEEP) for patients with acidosis and hypercapnia, particularly those with COPD history 1
- Proceed to intubation for patients progressing to grade III/IV encephalopathy or respiratory failure not responding to NIV 1
Pharmacological Management
Diuretic Therapy
- Administer IV furosemide:
Vasodilator Therapy
- For patients with SBP >110 mmHg:
Rate Control for Atrial Fibrillation
- Use beta-blockers as first-line treatment for rate control
- Consider IV cardiac glycoside for rapid ventricular rate control 1
ACE Inhibitors
- Consider lisinopril within 24 hours of stabilization for patients with:
- Hemodynamic stability (SBP >100 mmHg)
- No severe renal dysfunction (serum creatinine <2 mg/dL) 4
Medications to Use with Caution
- Avoid routine use of opioids - associated with higher rates of mechanical ventilation, ICU admission, and death 1
- Avoid vasopressors or sympathomimetics unless signs of hypoperfusion persist despite adequate filling status 1
- Avoid dobutamine when pulmonary edema is associated with normal or high systolic blood pressure 1
ICU Management Plan
Criteria for ICU Admission
- Respiratory rate >25/min
- SpO₂ <90% despite supplemental oxygen
- Need for NIV or mechanical ventilation
- Hemodynamic instability or shock
- Heart rate >150 bpm or <40 bpm
- Need for IV antihypertensive medication after first-line drugs have failed 1
ICU Management Priorities
Hemodynamic stabilization:
- Continuous hemodynamic monitoring
- Consider pulmonary artery catheterization for refractory cases
- Volume replacement if needed
- Pressor support only if persistent signs of hypoperfusion despite adequate filling status
Electrolyte management:
- Monitor potassium, magnesium, phosphate levels
- Adjust oral medications based on blood pressure, heart rate, potassium levels, and renal function according to the guideline table 1
Renal function monitoring:
- Avoid nephrotoxic agents
- Consider continuous modes of hemodialysis if needed for renal failure 1
Discharge Planning from ICU
Transfer from ICU when:
- Hemodynamically stable for >24 hours
- No longer requiring NIV or mechanical ventilation
- Improved symptoms of heart failure
- Stable renal function for at least 24 hours
- Established on appropriate oral medications
Arrange early follow-up (within 72 hours) after hospital discharge 2
Pitfalls to Avoid
- Overuse of fluid resuscitation - can worsen pulmonary edema
- Delayed initiation of NIV - early use reduces intubation rates
- Routine use of morphine - associated with worse outcomes
- Inappropriate use of vasopressors - not indicated if SBP >110 mmHg
- Neglecting rate control in atrial fibrillation - can worsen heart failure
By following this structured approach to medication management and ICU care, you can optimize outcomes for patients with acute heart failure while minimizing complications.